Asthika Goonewardene
Stock Analyst at Truist Securities
(0)
# 4755
Out of 5,343 analysts
109
Total ratings
34.29%
Success rate
-21.21%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
MRSN Mersana Therapeutics | Maintains: Strong Buy | 9 10 | 0.36 | 2677.78% | 4 | May 16, 2025 | |
LEGN Legend Biotech | Maintains: Buy | 88 71 | 28.79 | 146.61% | 2 | May 14, 2025 | |
ALLO Allogene Therapeutic... | Maintains: Buy | 14 10 | 1.1 | 809.09% | 7 | May 14, 2025 | |
AUTL Autolus Therapeutics | Maintains: Buy | 11 10 | 1.51 | 562.25% | 4 | Apr 1, 2025 | |
GMAB Genmab | Maintains: Buy | 50 45 | 21.08 | 113.47% | 14 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 15 | 1.77 | 747.46% | 6 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 32 7 | 4.12 | 69.9% | 3 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 42 43 | 43.35 | -0.81% | 8 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 12 2 | 1.19 | 68.07% | 8 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 172 | 98.65 | 74.35% | 1 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 35 | 25.94 | 34.93% | 1 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 87 136 | 65.5 | 107.63% | 5 | Nov 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 83 97 | 106.64 | -9.04% | 1 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 18 15 | 0.89 | 1585.39% | 6 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 50 44 | 8.66 | 408.08% | 1 | Jun 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 69 88 | 42.57 | 106.72% | 2 | Jun 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 5 4 | 1.4 | 185.71% | 5 | May 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 19 | 1.01 | 1781.19% | 3 | May 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Hold | 229 | n/a | n/a | 4 | Oct 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 | 1.7 | 2252.94% | 4 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 27 | 0.7 | 3757.14% | 2 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 15 18 | n/a | n/a | 2 | Jun 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Hold | 120 | 24.64 | 387.01% | 1 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 8 3 | n/a | n/a | 3 | Mar 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 20 | n/a | n/a | 3 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Hold | 100 60 | 2.35 | 2453.19% | 3 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 19 15 | 0.47 | 3091.49% | 4 | Aug 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Hold | 55 96 | n/a | n/a | 2 | Mar 3, 2020 |